Envista Announces Participation in 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Envista Holdings Corporation (NYSE: NVST) will participate in the 41^st Annual J.P. Morgan Healthcare Conference on January 9, 2023, from 3:00 – 3:40 PM PT at the Westin St. Francis Hotel in San Francisco. Investors can access a live audio webcast and recording on Envista's Investor Relations website for 30 days post-event. Envista is a leading global dental products company with a portfolio of over 30 trusted dental brands, including Nobel Biocare and Ormco, focused on improving lives through innovative dental solutions and technology.

Positive

• Participation in a significant industry conference, enhancing visibility.
• Strong brand recognition with over 30 trusted dental brands.
• Comprehensive portfolio addressing broad clinical needs in dentistry.

Negative

• None.

BREA, Calif., Dec. 22, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the 41^st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 from 3:00 – 3:40 PM PT at the Westin St. Francis Hotel in San Francisco.

Investors will be able to access a live audio webcast and recording through Envista's Investor Relations website under the subheading Events and Presentations for up to 30 days post event.

About Envista Holdings Corporation

Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, DEXIS, Ormco, and Kerr united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a broad range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.

For Further Information

Stephen Keller
Vice President, Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (714) 817-7000
Fax: (714) 817-5450

View original content to download multimedia:https://www.prnewswire.com/news-releases/envista-announces-participation-in-41st-annual-jp-morgan-healthcare-conference-301709336.html

SOURCE Envista Holdings Corporation

FAQ

When will Envista participate in the J.P. Morgan Healthcare Conference?

Envista will participate in the J.P. Morgan Healthcare Conference on January 9, 2023.

What time is Envista's presentation at the conference?

Envista's presentation is scheduled from 3:00 to 3:40 PM PT.

How can investors access Envista's conference presentation?

Investors can access a live audio webcast and recording through Envista's Investor Relations website.

What is Envista Holdings Corporation known for?

Envista is known for its trusted dental brands and a comprehensive portfolio of dental solutions and technology.

What stock symbol is associated with Envista Holdings Corporation?

The stock symbol for Envista Holdings Corporation is NVST.